Pasithea Therapeutics Corp (KTTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,923 | 16,331 | 33,088 | 52,967 | 244 |
| Other current assets | 143 | 145 | 426 | 0 | 0 |
| TOTAL | $7,368 | $16,692 | $34,077 | $53,301 | $248 |
| Non-Current Assets | |||||
| PPE Net | 122 | 141 | 125 | 20 | N/A |
| Intangibles | 8,574 | 9,204 | 9,834 | 0 | 0 |
| Other Non-Current Assets | 0 | 79 | 1,144 | 0 | 0 |
| TOTAL | $8,696 | $9,425 | $11,103 | $20 | $N/A |
| Total Assets | $16,065 | $26,117 | $45,180 | $53,321 | $248 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,120 | 2,552 | 1,481 | 447 | 7 |
| TOTAL | $1,120 | $2,634 | $1,878 | $447 | $7 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 162 | 84 | 804 | 1,453 | 0 |
| TOTAL | $162 | $84 | $804 | $1,453 | $N/A |
| Total Liabilities | $1,282 | $2,718 | $2,682 | $1,900 | $7 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,705 | 1,042 | 1,306 | 1,143 | N/A |
| Common Shares | 0 | 0 | 0 | 18 | 15 |
| Retained earnings | -49,583 | -35,319 | -19,357 | -2,215 | -41 |
| Other shareholders' equity | -7 | -5 | -1 | -11 | 0 |
| TOTAL | $14,783 | $23,399 | $42,498 | $51,421 | $241 |
| Total Liabilities And Equity | $16,065 | $26,117 | $45,180 | $53,321 | $248 |